Health In Tech (NASDAQ: HIT) CEO awarded 1M restricted shares in grant
Rhea-AI Filing Summary
Health In Tech, Inc. reported that Chief Executive Officer, director and 10% owner Tim Johnson received a grant of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at a price of $0 per share under the Health In Tech Equity Incentive Plan. The grant is tied to two proposed issuer transactions: half of the shares vest in equal monthly installments over 12 months starting at the closing of the first transaction, and the other half vest monthly over 12 months starting at the closing of the second transaction, in each case subject to continued service.
If either transaction does not close within 24 months after January 6, 2026, any unvested shares relating to that transaction will be automatically forfeited without consideration. Following this award, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, including 1,126,130 restricted shares and 22,423,611 unrestricted shares.
Positive
- None.
Negative
- None.
Insights
CEO receives 1,000,000 contingent RSs tied to two proposed deals.
The filing shows Health In Tech, Inc. granting CEO Tim Johnson 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 at $0 per share under the company’s equity incentive plan. This is a stock-based compensation award rather than a cash transaction, and it is structured around two proposed issuer transactions, described as separate “Transactions.”
Half of the award vests in equal monthly installments over 12 months starting at the closing of the first Transaction, and the other half vests monthly over 12 months starting at the closing of the second Transaction, with vesting conditioned on continued service. The terms also state that if either Transaction does not close within 24 months after the Grant Date, any unvested shares tied to that Transaction are automatically forfeited without consideration, linking the realized value of the award to deal completion.
After this grant, Johnson beneficially owns 23,549,741 shares of Class A Common Stock, comprised of 1,126,130 restricted shares and 22,423,611 unrestricted shares. The award increases his equity stake but with vesting and forfeiture conditions that depend on both the closing of the proposed Transactions and his ongoing service, so the ultimate impact will follow future transaction and vesting outcomes disclosed in subsequent filings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 1,000,000 | $0.00 | -- |
Footnotes (1)
- Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration. Includes 1,126,130 shares of restricted shares of Class A Common Stock and 22,423,611 unrestricted shares of Class A Common Stock. Excludes 9,000,000 shares of Class B Common Stock and 734,707 options to purchase shares of Class A Common Stock.
